New daily persistent headache

Current Opinion in Neurology

Volumn 24, Issue 3, 2011, Pages 211-216

  Rozen, Todd D ^a,b  

^a GEISINGER MEDICAL CENTER   (United States)

^b MC 37 31 ^*  (United States)

Author keywords

cervical hypermobility; chronic daily headache; new daily persistent headache; tumor necrosis factor alpha

Indexed keywords

DOXYCYCLINE; GABAPENTIN; METHYLPREDNISOLONE; MEXILETINE; TOPIRAMATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CEREBROSPINAL FLUID; CERVICAL SPINE; CLINICAL FEATURE; DRUG MEGADOSE; HUMAN; JOINT HYPERMOBILITY; MEDICAL LITERATURE; NEW DAILY PERSISTENT HEADACHE; PATHOGENESIS;

CERVICAL VERTEBRAE; CLINICAL TRIALS AS TOPIC; DIAGNOSIS, DIFFERENTIAL; HEADACHE DISORDERS; HUMANS; JOINT INSTABILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955626575     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328345c5ad     Document Type: Article

References (19)

1. Vanast WJ. New daily persistent headaches: definition of a benign syndrome. Headache 1986; 26:317.
2. Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia 2002; 22:66-69. (Pubitemid 34626027)
3. Kung E, Tepper SJ, Rapoport AM, et al. New daily persistent headache in a paediatric population. Cephalalgia 2009; 29:17-22.
4. Robbins MS, Grosberg BM, Napchan U, et al. Clinical and prognostic subforms of new daily-persistent headache. Neurology 2010; 74:1358-1364.
5. Diaz-Mitoma F, Vanast WJ, Tyrell DL. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 1987; 1:411-415. (Pubitemid 17016581)
6. Santoni JR, Santoni-Williams CJ. Headache and painful lymphadenopathy in extracranial or systemic infection: etiology of new daily persistent headaches. Intern Med 1993; 32:530-533.
7. Rozen TD, Roth JM, Denenberg N. Joint hypermobility as a predisposing factor for the development of new daily persistent headache. Headache 2005; 45:828-829.
8. Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Headache Rep 2003; 2:155-161.
9. Piovesan EJ, Kowacs PA, Tatsui CE, et al. Referred pain after painful stimulation of the greater occipital nerve in humans: evidence of convergence of cervical afferences on trigeminal nuclei. Cephalalgia 2001; 21:107-109. (Pubitemid 32575473)
10. Rozen TD, Swidan S. Elevation of CSF tumor necrosis factor alpha levels in NDPH and treatment refractory chronic daily migraine. Headache 2006; 46:897.
11. Olson JK, Girvin AM, Miller SD. Direct activation of innate and antigenpresenting functions of microglia following infection with Theiler's virus. J Virol 2001; 75:9780-9789. (Pubitemid 32900113)
12. O'Conner KA, Johnson JD, Hansen MK, et al. Peripheral and central proin-flammatory cytokine response to a severe acute stressor. Brain Res 2003; 991:123-132. (Pubitemid 37297941)
13. Fu D, Guo Q, Ai Y, et al. Glial activation and segmental upregulation of interleukin-1b (IL-1b) in the rat spinal cord after surgical incision. Neurochem Res 2006; 31:333-340. (Pubitemid 43829322)
14. Durham PL. Calcitonin gene-related peptide (CGRP) and migraine. Headache 2006; 46 (Suppl 1):3-8.
15. Rozen TD. Successful treatment of new daily persistent headache with gabapentin and topiramate. Headache 2002; 42:433.
16. Rozen TD. Doxycycline for treatment resistant new daily persistent headache. Neurology 2008; 70 (Suppl 1):A348.
17. Marmura MJ, Passero FC, Young WB. Mexiletine for refractory chronic daily headache: a report of nine cases. Headache 2008; 48:1506-1510.
18. Prakash S, Shah ND. Post-Infectious new daily persistent headache may respond to intravenous methylprednisolone. J Headache Pain 2010; 1:59-66.
19. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004; 24 (Suppl 1): 9-160.